DOI: 10.1016/S0140-6736(23)02190-6

Paper Summary:

Title: Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial

Author(s): Kaul, Inder (author);Sawchak, Sharon (author);Correll, Christoph U (author);Kakar, Rishi (author);Breier, Alan (author);Zhu, Haiyuan (author);Miller, Andrew C (author);Paul, Steven M (author);Brannan, Stephen K (author)

Year: 2024

DOI: 10.1016/S0140-6736(23)02190-6

URL: https://doi.org/10.1016/S0140-6736(23)02190-6

Download Paper

Received on: 2024-10-23

✍: FYIcenter.com

2024-11-05, ∼377👍, 0💬